Avanos Medical (AVNS) EBT Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 329.00 |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 988.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 988.00 |
| Dec 31, 2025 | -721.00 |
| Sep 30, 2025 | -654.00 |
| Jun 30, 2025 | -4,782.00 |
| Mar 31, 2025 | 209.00 |
| Dec 31, 2024 | -16,961.00 |
| Sep 30, 2024 | 411.00 |
| Jun 30, 2024 | 763.00 |
| Mar 31, 2024 | 876.00 |
| Dec 31, 2023 | 3,205.00 |
| Sep 30, 2023 | 74.00 |
| Jun 30, 2023 | 59.00 |
| Mar 31, 2023 | -405.00 |
| Dec 31, 2022 | 1,130.00 |
| Sep 30, 2022 | 1,771.00 |
| Jun 30, 2022 | 1,101.00 |
| Mar 31, 2022 | 1,947.00 |
| Dec 31, 2021 | -5,899.00 |
| Sep 30, 2021 | -156.00 |
| Jun 30, 2021 | -471.00 |
| Mar 31, 2021 | 160.00 |
| Dec 31, 2020 | -2,079.00 |
| Sep 30, 2020 | 957.00 |
| Jun 30, 2020 | 941.00 |
| Mar 31, 2020 | 1,536.00 |
| Dec 31, 2019 | -3,371.00 |
| Sep 30, 2019 | -1,504.00 |
| Jun 30, 2019 | -891.00 |
| Mar 31, 2019 | -2,235.00 |
| Dec 31, 2018 | 3,280.00 |
| Sep 30, 2018 | 12,344.00 |
| Jun 30, 2018 | -273.00 |
| Mar 31, 2018 | -1,776.00 |
| Dec 31, 2017 | -1,025.00 |
| Sep 30, 2017 | -1,525.00 |
| Jun 30, 2017 | -1,214.00 |
| Mar 31, 2017 | -3,229.00 |
| Dec 31, 2016 | 1,672.00 |
| Sep 30, 2016 | -1,373.00 |